From: Diagnostic value of circN4BP2L2 in type I and type II epithelial ovarian cancer
Parameter | EOC (n = 180) | Type I EOC (n = 70) | Type II EOC (n = 110) | ||||||
---|---|---|---|---|---|---|---|---|---|
n (%) | CircN4BP2L2, Mean ± SD | p | n (%) | CircN4BP2L2, Mean ± SD | p | n (%) | CircN4BP2L2, Mean ± SD | p | |
Age | Â | Â | 0.52 | Â | Â | 0.70 | Â | Â | 0.47 |
 ≤ 50y | 54 (30%) | 27.48 ± 21.15 |  | 17 (24%) | 30.24 ± 24.74 |  | 37 (34%) | 26.21 ± 19.52 |  |
 > 50y | 126 (70%) | 26.70 ± 22.51 |  | 53 (76%) | 31.04 ± 24.92 |  | 73 (66%) | 23.54 ± 20.19 |  |
Histology | Â | Â | 0.75 | Â | Â | 0.11 | Â | Â | 0.76 |
 Serous | 106 (59%) | 27.01 ± 22.88 |  | 18 (26%) | 40.11 ± 30.81 |  | 88 (80%) | 28.53 ± 22.19 |  |
 Others | 74 (41%) | 26.81 ± 20.98 |  | 52 (74%) | 27.64 ± 21.64 |  | 22 (20%) | 23.30 ± 19.22 |  |
FIGO stage |  |  | < 0.01* |  |  | < 0.01* |  |  | 0.44 |
 I + II | 64 (36%) | 35.19 ± 25.19 |  | 40 (57%) | 39.19 ± 26.29 |  | 24 (22%) | 39.19 ± 26.29 |  |
 III + IV | 116 (64%) | 22.38 ± 18.73 |  | 30 (43%) | 19.73 ± 17.27 |  | 86 (78%) | 19.73 ± 17.27 |  |
Grade | Â | Â | 0.03* | Â | Â | 0.15 | Â | Â | NA |
 G1 | 54 (30%) | 32.69 ± 25.61 |  | 54 (77%) | 32.69 ± 25.61 |  | 0 (0%) | NA |  |
 G2 + G3 | 126 (70%) | 24.47 ± 19.96 |  | 16 (23%) | 24.64 ± 20.88 |  | 110 (100%) | 24.44 ± 19.92 |  |
LNM a |  |  | < 0.01* |  |  | 0.70 |  |  | 0.04* |
 Yes | 59 (40%) | 19.71 ± 15.11 |  | 8 (14%) | 19.27 ± 10.81 |  | 51 (57%) | 19.78 ± 15.76 |  |
 No | 89 (60%) | 30.46 ± 23.00 |  | 50 (86%) | 31.61 ± 24.55 |  | 39 (43%) | 29.00 ± 21.07 |  |